Tonix Pharmaceuticals Holding Corp - Common Stock (TNXP)

CUSIP: 890260854

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
186,616,143
Total 13F shares
1,023,358
Share change
+1,023,356
Total reported value
$1,616,253
Price per share
$1.58
Number of holders
30
Value change
+$1,616,250
Number of buys
29

Quarterly Holders Quick Answers

What is CUSIP 890260854?
CUSIP 890260854 identifies TNXP - Tonix Pharmaceuticals Holding Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TNXP - Tonix Pharmaceuticals Holding Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
class O/S missing
2,427,778
$1,435,060 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
1,222,424
$723,000 31 Mar 2023
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
class O/S missing
1,100,419
$650,458 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
class O/S missing
711,969
$420,845 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
533,511
$315,358 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
class O/S missing
301,858
$178,429 31 Mar 2023
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
293,036
$173,000 31 Mar 2023
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
class O/S missing
266,188
$157,344 31 Mar 2023
13F
STATE STREET CORP
13F
Company
class O/S missing
195,028
$115,281 31 Mar 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
class O/S missing
160,347
$94,000 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
101,887
$60,226 31 Mar 2023
13F
HANTZ FINANCIAL SERVICES, INC.
13F
Company
class O/S missing
85,690
$51,000 31 Mar 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
class O/S missing
60,191
$35,579 31 Mar 2023
13F
Virtu Financial LLC
13F
Company
class O/S missing
58,883
$35,000 31 Mar 2023
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
class O/S missing
38,359
$22,000 31 Mar 2023
13F
Simplicity Solutions, LLC
13F
Company
class O/S missing
36,670
$21,676 31 Mar 2023
13F
UBS Group AG
13F
Company
class O/S missing
25,795
$15,245 31 Mar 2023
13F
TWO SIGMA SECURITIES, LLC
13F
Company
class O/S missing
24,303
$14,366 31 Mar 2023
13F
Daniel Wintner Goodman
3/4/5
Director
class O/S missing
5,001
$8,552 25 May 2021
EDMOND DE ROTHSCHILD HOLDING S.A.
13F
Company
class O/S missing
9,375
$5,542 31 Mar 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
class O/S missing
5,849
$3,456 31 Mar 2023
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
class O/S missing
1,005
$594 31 Mar 2023
13F
NVWM, LLC
13F
Company
class O/S missing
869
$514 31 Mar 2023
13F
FEDERATED HERMES, INC.
13F
Company
class O/S missing
736
$435 31 Mar 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
421
$249 31 Mar 2023
13F
Global Retirement Partners, LLC
13F
Company
class O/S missing
391
$192 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
264
$156 31 Mar 2023
13F
Focused Wealth Management, Inc
13F
Company
class O/S missing
222
$131 31 Mar 2023
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
class O/S missing
158
$93 31 Mar 2023
13F
Beaird Harris Wealth Management, LLC
13F
Company
class O/S missing
79
$47 31 Mar 2023
13F
Gradient Investments LLC
13F
Company
class O/S missing
63
$37 31 Mar 2023
13F
North Star Investment Management Corp.
13F
Company
class O/S missing
38
$22 31 Mar 2023
13F
IFP Advisors, Inc
13F
Company
class O/S missing
7
$15 31 Mar 2023
13F
Twin Lakes Capital Management, LLC
13F
Company
class O/S missing
18
$11 31 Mar 2023
13F
Global Wealth Strategies & Associates
13F
Company
class O/S missing
17
$10 31 Mar 2023
13F
Advisory Services Network, LLC
13F
Company
class O/S missing
1
$1 31 Mar 2023
13F
HARBOR INVESTMENT ADVISORY, LLC
13F
Company
class O/S missing
1
$1 31 Mar 2023
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
class O/S missing
1
$1 31 Mar 2023
13F
Tradewinds Capital Management, LLC
13F
Company
class O/S missing
1
$1 31 Mar 2023
13F

Institutional Holders of Tonix Pharmaceuticals Holding Corp - Common Stock (TNXP) as of Q2 2023

As of 30 Jun 2023, Tonix Pharmaceuticals Holding Corp - Common Stock (TNXP) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,023,358 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., RAYMOND JAMES & ASSOCIATES, JPMORGAN CHASE & CO, STATE STREET CORP, BANK OF AMERICA CORP /DE/, and TWO SIGMA SECURITIES, LLC. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q2 2024 Across Filers

Q2 2024 holders
2
Q2 2023 holders
30
Holder diff
28
Investor Q2 2024 Shares Q2 2023 Shares Share Diff Share Chg % Q2 2024 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .